Cargando…

Ultra rapid in vivo screening for anti-Alzheimer anti-amyloid drugs

More than 46 million people worldwide suffer from Alzheimer’s disease. A large number of potential treatments have been proposed; among these, the inhibition of the aggregation of amyloid β-peptide (Aβ), considered one of the main culprits in Alzheimer’s disease. Limitations in monitoring the aggreg...

Descripción completa

Detalles Bibliográficos
Autores principales:	Espargaró, Alba, Medina, Aina, Di Pietro, Ornella, Muñoz-Torrero, Diego, Sabate, Raimon
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2016
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4802339/ https://www.ncbi.nlm.nih.gov/pubmed/27000658 http://dx.doi.org/10.1038/srep23349

Ejemplares similares

Dual Inhibitors of Amyloid-β and Tau Aggregation with Amyloid-β Disaggregating Properties: Extended In Cellulo, In Silico, and Kinetic Studies of Multifunctional Anti-Alzheimer’s Agents
por: Pasieka, Anna, et al.
Publicado: (2021)

Using bacterial inclusion bodies to screen for amyloid aggregation inhibitors
por: Villar-Piqué, Anna, et al.
Publicado: (2012)

Characterization of the amyloid bacterial inclusion bodies of the HET-s fungal prion
por: Sabaté, Raimon, et al.
Publicado: (2009)

Yeast prions form infectious amyloid inclusion bodies in bacteria
por: Espargaró, Alba, et al.
Publicado: (2012)

Key Points Concerning Amyloid Infectivity and Prion-Like Neuronal Invasion
por: Espargaró, Alba, et al.
Publicado: (2016)

Could α-Synuclein Amyloid-Like Aggregates Trigger a Prionic Neuronal Invasion?
por: Busquets, Maria Antònia, et al.
Publicado: (2015)

Amyloids in solid-state nuclear magnetic resonance: potential causes of the usually low resolution
por: Espargaró, Alba, et al.
Publicado: (2015)

Three to Tango: Inhibitory Effect of Quercetin and Apigenin on Acetylcholinesterase, Amyloid-β Aggregation and Acetylcholinesterase-Amyloid Interaction
por: Álvarez-Berbel, Irene, et al.
Publicado: (2022)

Magnetic Nanoparticles Cross the Blood-Brain Barrier: When Physics Rises to a Challenge
por: Busquets, Maria Antònia, et al.
Publicado: (2015)

Azobioisosteres of Curcumin with Pronounced Activity against Amyloid Aggregation, Intracellular Oxidative Stress, and Neuroinflammation
por: Hofmann, Julian, et al.
Publicado: (2021)

Evidence of Protein Adsorption in Pegylated Liposomes: Influence of Liposomal Decoration
por: Sangrà, Marc, et al.
Publicado: (2017)

Pharmacophore Modeling and 3D-QSAR Study of Indole and Isatin Derivatives as Antiamyloidogenic Agents Targeting Alzheimer’s Disease †
por: Purgatorio, Rosa, et al.
Publicado: (2020)

Multigram Synthesis and in Vivo Efficacy Studies of a Novel Multitarget Anti-Alzheimer’s Compound
por: Sola, Irene, et al.
Publicado: (2015)

Unveiling the Multitarget Anti-Alzheimer Drug Discovery Landscape: A Bibliometric Analysis
por: Sampietro, Anna, et al.
Publicado: (2022)

New cyclopentaquinoline and 3,5-dichlorobenzoic acid hybrids with neuroprotection against oxidative stress for the treatment of Alzheimer’s disease
por: Czarnecka, Kamila, et al.
Publicado: (2023)

Special Issue: “Molecules against Alzheimer”
por: Decker, Michael, et al.
Publicado: (2016)

Anti-Amyloid Therapies for Alzheimer’s Disease and the Amyloid Cascade Hypothesis
por: Fedele, Ernesto
Publicado: (2023)

Anti-amyloid: An antibody to cure Alzheimer’s or an attitude
por: Osborne, Olivia M., et al.
Publicado: (2023)

Anti-amyloid therapies work for Alzheimer’s disease
por: Hardy, John
Publicado: (2023)

Discovery of Dual Aβ/Tau Inhibitors and Evaluation of Their Therapeutic Effect on a Drosophila Model of Alzheimer’s Disease
por: Gandini, Annachiara, et al.
Publicado: (2022)

A Combined Chronic Low-Dose Soluble Epoxide Hydrolase and Acetylcholinesterase Pharmacological Inhibition Promotes Memory Reinstatement in Alzheimer’s Disease Mice Models
por: Jarne-Ferrer, Júlia, et al.
Publicado: (2022)

Potential applications of magnetic particles to detect and treat Alzheimer's disease
por: Busquets, Maria Antònia, et al.
Publicado: (2014)

Are we ready to use anti-amyloid therapy in Alzheimer's disease?
por: Brucki, Sonia Maria Dozzi, et al.
Publicado: (2022)

Unveiling the Potential of Polyphenols as Anti-Amyloid Molecules in Alzheimer’s Disease
por: Kabir, Eva Rahman, et al.
Publicado: (2023)

Amyloid-Related Imaging Abnormalities With Anti-amyloid Antibodies for the Treatment of Dementia Due to Alzheimer's Disease
por: Withington, Charles G., et al.
Publicado: (2022)

Correction: Unveiling a novel transient druggable pocket in BACE-1 through molecular simulations: Conformational analysis and binding mode of multisite inhibitors
por: Di Pietro, Ornella, et al.
Publicado: (2017)

Unveiling a novel transient druggable pocket in BACE-1 through molecular simulations: Conformational analysis and binding mode of multisite inhibitors
por: Di Pietro, Ornella, et al.
Publicado: (2017)

Moving beyond anti-amyloid therapy for the prevention and treatment of Alzheimer’s disease
por: Castello, Michael A, et al.
Publicado: (2014)

Anti-Amyloid-β Monoclonal Antibodies for Alzheimer’s Disease: Pitfalls and Promise
por: van Dyck, Christopher H.
Publicado: (2017)

Anti-amyloid therapies for Alzheimer disease: finally, good news for patients
por: Ramanan, Vijay K., et al.
Publicado: (2023)

Anti-Amyloid Immunotherapies for Alzheimer’s Disease: A 2023 Clinical Update
por: Yadollahikhales, Golnaz, et al.
Publicado: (2023)

If amyloid drives Alzheimer disease, why have anti-amyloid therapies not yet slowed cognitive decline?
por: Haass, Christian, et al.
Publicado: (2022)

Amyloid-Like Protein Inclusions in Tobacco Transgenic Plants
por: Villar-Piqué, Anna, et al.
Publicado: (2010)

Intracellular amyloid hypothesis for ultra‐early phase pathology of Alzheimer's disease
por: Okazawa, Hitoshi
Publicado: (2021)

Structure‐Based Virtual Screening and in vitro and in vivo Analyses Revealed Potent Methyltransferase G9a Inhibitors as Prospective Anti‐Alzheimer's Agents
por: Bellver‐Sanchis, Aina, et al.
Publicado: (2022)

Rapid in vivo measurement of β-amyloid reveals biphasic clearance kinetics in an Alzheimer’s mouse model
por: Yuede, Carla M., et al.
Publicado: (2016)

Brain amyloid burden, sleep, and 24-hour rest/activity rhythms: screening findings from the Anti-Amyloid Treatment in Asymptomatic Alzheimer’s and Longitudinal Evaluation of Amyloid Risk and Neurodegeneration Studies
por: Spira, Adam P, et al.
Publicado: (2021)

Anti-amyloid-beta to tau-based immunization: developments in immunotherapy for Alzheimer’s disease
por: Lambracht-Washington, Doris, et al.
Publicado: (2013)

Passive anti-amyloid immunotherapy in Alzheimer's disease: What are the most promising targets?
por: Moreth, Jens, et al.
Publicado: (2013)

Anti-amyloid aggregation activity of novel carotenoids: implications for Alzheimer’s drug discovery
por: Lakey-Beitia, Johant, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_vf3ansbte539c8nbc0h39641e9